What's Happening?
Mae Horne, a doctoral candidate in the Department of Infectious Diseases and Microbiology at the University of Pittsburgh School of Public Health, has been awarded the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship
(Parent F31). This three-year, $150,342 grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, will fund her project titled "Viral determinants of host entry factor engagement in chikungunya virus infection." The research aims to investigate how the chikungunya virus, a re-emerging mosquito-borne pathogen, interacts with host cells to initiate infection. Chikungunya virus causes fever and muscle pain, often progressing to severe, long-term chronic polyarthritis, and has spread globally, putting nearly half of the world's population at risk. Currently, there are no approved therapeutics for the virus, making research into its mechanisms crucial for developing new treatments.
Why It's Important?
This research is significant because chikungunya virus poses a substantial global health threat, with recurring outbreaks leading to prolonged illness and considerable socioeconomic burden. The lack of approved treatments means that understanding the fundamental mechanisms of viral infection is critical for therapeutic development. Horne's study will focus on how specific residues in the virus's E2 surface glycoprotein modulate interactions with host entry factors, including carbohydrate attachment factors and protein receptors like MXRA8. By clarifying how strain-specific variations influence viral infectivity, replication, and cellular tropism, the project could identify clear targets for future therapies. This foundational knowledge is essential for creating effective antiviral drugs or vaccines, which are currently unavailable, thereby addressing a major unmet medical need.
What's Next?
Over the next three years, Mae Horne will conduct her research in the lab of Dr. Laurie Silva, assistant professor in the Department of Infectious Diseases and Microbiology, who will serve as her primary mentor. Horne will employ targeted mutagenesis, structural modeling, and functional virological assays to uncover the exact viral mechanisms that allow different strains of the virus to attach to and enter host cells. The findings from this fellowship are expected to lay the groundwork for novel receptor-based therapeutics. Success in identifying these viral mechanisms could lead to the development of new antiviral strategies, potentially offering relief to millions at risk of chikungunya infection and its debilitating long-term effects.
Beyond the Headlines
The broader implications of this research extend beyond immediate therapeutic development. By delving into the molecular intricacies of viral entry, Horne's work contributes to a deeper understanding of host-pathogen interactions, which can inform strategies for combating other emerging infectious diseases. The study highlights the importance of basic scientific research in addressing global health challenges, particularly for neglected tropical diseases like chikungunya. Furthermore, the grant underscores the ongoing commitment of institutions like the National Institutes of Health to support young scientists in critical areas of public health. The insights gained could also influence public health policies related to disease surveillance and outbreak response, especially in regions where chikungunya is endemic or emerging.
